statistiche ricercatore

Continente	#
NA - Nord America	1.158
EU - Europa	481
AS - Asia	307
Continente sconosciuto - Info sul continente non disponibili	31
SA - Sud America	29
AF - Africa	6
OC - Oceania	1
Totale	2.013

Nazione	#
US - Stati Uniti d'America	1.142
IT - Italia	245
SG - Singapore	89
CN - Cina	75
UA - Ucraina	53
DE - Germania	46
VN - Vietnam	44
HK - Hong Kong	38
SE - Svezia	38
GB - Regno Unito	23
TR - Turchia	21
BR - Brasile	20
BD - Bangladesh	19
IE - Irlanda	16
FI - Finlandia	12
FR - Francia	10
RU - Federazione Russa	10
MX - Messico	7
CZ - Repubblica Ceca	6
CA - Canada	5
IN - India	5
JP - Giappone	5
LT - Lituania	4
ES - Italia	3
RO - Romania	3
AR - Argentina	2
BE - Belgio	2
GP - Guadalupe	2
ID - Indonesia	2
IQ - Iraq	2
KR - Corea	2
MK - Macedonia	2
NL - Olanda	2
PE - Perù	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AO - Angola	1
AT - Austria	1
AU - Australia	1
BG - Bulgaria	1
CG - Congo	1
CI - Costa d'Avorio	1
CL - Cile	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EE - Estonia	1
EU - Europa	1
GR - Grecia	1
HU - Ungheria	1
JO - Giordania	1
KG - Kirghizistan	1
KZ - Kazakistan	1
NG - Nigeria	1
PL - Polonia	1
SA - Arabia Saudita	1
SV - El Salvador	1
TZ - Tanzania	1
UY - Uruguay	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	1.984

Nome	#
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study	270
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management	263
Masked hypertension in newly diagnosed hypothyroidism: a pilot study	258
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial	235
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study	225
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?	223
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity	223
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe	219
Recidiva linfonodale di carcinoma papillare tiroideo in paziente affetto da sarcoidosi	97
Totale	2.013

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	99	0	0	0	4	7	14	5	5	15	34	5	10
2022/2023	153	10	22	10	14	10	30	2	22	20	5	2	6
2023/2024	255	41	43	36	51	44	23	1	0	4	6	0	6
2024/2025	148	0	2	22	12	9	13	4	13	3	14	14	42
2025/2026	449	48	16	27	72	44	25	90	30	32	31	25	9
2026/2027	109	24	26	40	19	0	0	0	0	0	0	0	0
Totale													2.013